金黄色葡萄球菌肠毒素A Asp227Ala基因的克隆及表达

目的：金黄色葡萄球菌肠毒素A Asp227ala基因的克隆及表达。方法：利用错配PCR方法,从含有金黄色葡萄球菌肠毒素A（Staphylococcal enterotoxn A,SEA)基因的质粒中扩增出约720bp的DNA片段,将其克隆到表达载体7ZTS中,并转化于JM109（DE3）。结果：重组质粒的测序结果表明,它含有702bp（不包括N端72bp的信号肽编码区）,其核苷酸序列与文献报道完全一致,推导的氨基酸序列显示227位的天冬氨酸已突变为丙氨酸。结论：该基因所表达的蛋白为可溶性蛋白,表达量占总蛋白51.5%。表达的蛋白与天然肠毒素A产生的抗体能发生凝集作用,具有与天然SEA类同的抗原活性。     

快速检测金黄色葡萄球菌肠毒素A基因方法的建立与应用

目的建立一种快速准确定量检测金黄色葡萄球菌肠毒素A的方法。方法以femB、SEA基因分别作为金黄色葡萄球菌菌株、肠毒素A的靶序列,设计合成引物和TaqM an探针;收集腹泻患者大便标本分离的金黄色葡萄球菌68株,并定量检测其肠毒素A。结果TaqM an探针荧光聚合酶链反应检测金黄色葡萄球和肠毒素A的灵敏度均为1.0×102拷贝。68株金黄色葡萄球菌中检出产肠毒素A菌株11例(16.2%,11/68),CT值为13.5~20.6。结论TaqM an探针荧光聚合酶链反应能够准确快速检测金黄色葡萄球菌肠毒素A。     

金黄色葡萄球菌肠毒素C的原核表达、纯化及活性鉴定

目的：在大肠杆菌中表达金黄色葡萄球菌肠毒素C（SEC）,并对其活性进行检测。方法：以金黄色葡萄球菌基因组为模板扩增SEC基因,经测序正确后插入原核表达载体pBV220中,转化大肠杆菌DH5α后温度热诱导重组SEC表达;表达产物经阳离子柱纯化后,用ELISA鉴定其抗原性;通过观测表达产物对鼠脾淋巴细胞的刺激增殖情况,检测其超抗原活性。结果：构建了SEC-pBV220原核表达载体,在大肠杆菌中可快速、高效表达SEC蛋白,表达产物具有超抗原活性。结论：实现了SEC的原核表达。     

超抗原SEA与抗黑色素瘤ScFv融合基因的构建及表达

采用酶切连接和重叠PCR连接两种方法将抗黑色素瘤单链抗体基因和去除N端信号肽的金黄色葡萄球菌肠毒素A基因进行融合,并将融合基因克隆于pET28a表达载体上,转化大肠杆菌BL21(DE3)。用NiNTA系统对表达产物进行分离、纯化。MTT法检测融合蛋白对黑色素瘤细胞的体外抑制率。结果表明6HisScFvSEA融合蛋白可在E.coli BL21(DE3)中稳定表达,表达量占菌体蛋白的30%,主要以包涵体的形式存在。融合蛋白可通过激活效应细胞对表达相关抗原的黑色素瘤细胞发挥抑制作用。     

口蹄疫病毒三价复合多表位佐剂DNA疫苗构建及其免疫原性

以O型、A型口蹄疫病毒(FMDV)结构蛋白VP1全基因和AsiaI型FMDV两个基因拓扑型的结构蛋白VP1基因上的5个抗原表位基因作为主要免疫原基因,以来源于非结构蛋白3ABC和结构蛋白VP4上的3个Th2细胞表位基因作为辅助基因,构建了O型、A型和Asia1型FMDV复合多表位基因工程疫苗表达盒OAAT,在此基础上,以金黄色葡萄球菌肠毒素A(SEA)为基因佐剂,通过分子设计构建了SEA与OAAT融合表达基因。将构建好的表达盒OAAT与SEA融合表达基因克隆至真核表达载体PVAX1PCMV启动子下游,构建了口蹄疫三价基因佐剂DNA疫苗pEA。经Western blotting和IFA检测,目的蛋白在Hela细胞中获得正确表达。小鼠免疫实验表明,pA和pEA免疫组的血清抗体均能分别与O型、A型和AsiaI抗原反应,与对照组相比差异较显著,且pEA免疫组和灭活疫苗免疫组抗体水平均显著高于pA免疫组;同时pA和pEA免疫小鼠细胞因子IL-2、IFN-γ、IL-4和IL-10较对照组显著提高,且pEA免疫组的IL-2、IFN-γ和IL-4水平明显高于pA免疫组。用O/NY00和Asia1/YNBS/58株FMDV进行...     

产肠毒素大肠杆菌的热敏肠毒素B亚基(LT-B)和耐热肠毒素(ST)基因融合及其表达

采用基因重组技术构建了表达产肠毒素大肠杆菌(ETEC)的耐热肠毒素(ST)基因和热敏肠毒素B亚基(LT-B)基因融合抗原的疫苗候选株。将ST基因的5’端与LT-B基因的3’端连接,并置于同一阅读框。编码ST的基因是通过PCR从pSLM004质粒中扩增得到的,含有ST的pro序列(其编码ST前体的pro区域),并应用寡核苷酸定点突变技术将编码ST的第14位氨基酸残基发生突变,使ST的第14位氨基酸残基Ala突变为Leu。在所构建的结构中,于LT-B和proST之间分别插入了不同长度的氨基酸Linkers。表达的融合多肽同时具有ST和LT-B的抗原性,并保留结合GM-1神经节苷脂的能力,且无LT和ST的生物毒性。表达的融合蛋白免疫动物,能诱导产生相应的特异性抗体。     

PCR检测食品中金黄色葡萄球菌肠毒素基因

目的：检测食品中金黄色葡萄球菌肠毒素基因谱携带情况,探讨与食物中毒发病相关的金黄色葡萄球菌基因类型。方法：取食品中检出的金黄色葡萄球菌进行分离培养鉴定,通过PCR技术检测样本18种不同型的肠毒素基因的携带情况,并进行统计学分析。结果：食品中检出的金黄色葡萄球菌肠毒素基因有较高的阳性检出率,主要检出sea、seb、sei、seg、sel、sem、sen等基因,其中sea基因检出率最高,达到77.27%;sei、seg、sem、sen基因具有相关性,检出率为9.09%;seb、sel基因的检出率为4.55%。结论：在食品中主要检出金黄色葡萄球菌肠毒素sea、sei、seg、sem、sen、seb、sel等基因,其中,sei、seg、sem、sen基因的相关性还有待进一步深入研究。     

金黄色葡萄球菌肠毒素A、B、C、D、E重组载体的构建及表达

金黄色葡萄球菌肠毒素（Staphylococcal enterotoxins，SEs）是一组结构毒力相似、血清型不同的可溶性小分子蛋白质，平均分子质量为26~30 kD，是引起细菌性食物中毒及肠胃炎的主要因素之一。为了制备金黄色葡萄球菌肠毒素的纯品，首先合成了SEA、SEB、SEC、SED和SEE的基因序列，然后构建了5种肠毒素的原核表达载体，分别转入BL21（DE3）细胞中进行诱导表达。通过SDS-PAGE和Western blot验证，5种肠毒素蛋白均被成功表达，并且在较低的诱导温度（16 ℃）获得一定量的可溶性蛋白。成功制备了5种金黄色葡萄球菌肠毒素的可溶性蛋白，为今后更好地解决因SEs引起的食品安全问题奠定了基础。     

安徽不同地区奶站牛奶中金黄色葡萄球菌及其肠毒素污染状况评估

目的评定安徽地区各奶站牛奶中金黄色葡萄球菌以及肠毒素的污染情况。方法通过从安徽省不同地区30所奶站采集乳样,进行乳源性金黄色葡萄球菌的分离与生化鉴定,并采用PCR技术对分离出的菌株进行金黄色葡萄球菌肠毒素血清型鉴定。结果安徽省30个奶站中有4个地区奶站的牛奶中污染金黄色葡萄球菌;从污染牛奶中共分离出5株金黄色葡萄球菌,检出率为16.7%。经鉴定,所分离出的金黄色葡萄球菌中2株为肠毒素A型,1株为肠毒素C型,2株为同时产肠毒素A和肠毒素C。结论安徽省不同地区奶站中的牛奶污染的金黄色葡萄球菌产肠毒素类型以肠毒素A为主。     

肠毒素C2中Met24对其超抗原活性无重要作用

目的:分析金黄色葡萄球菌肠毒素C2的T细胞受体结合区域α3结构中,第24位甲硫氨酸对其超抗原活性的影响作用.方法:应用定点突变技术对金黄色葡萄球菌肠毒素C2的Met24进行无意义突变,获得突变蛋白SEC2(M24A),对突变蛋白和野生型蛋白的体内、体外超抗原活性进行比较.结果:分别对野生型蛋白及突变蛋白的免疫刺激活性、肿瘤抑制活性、体内致热毒性进行了比较,发现突变蛋白的增值指数(PI)、抑瘤率、热源效应与野生型相比无显著差异(P＞0.05),这表明对第24位甲硫氨酸的替换没有对金黄色葡萄球菌肠毒素C2的超抗原活性造成明显影响.结论:在金黄色葡萄球菌肠毒素C2的α3结构中,Met24并不是决定其超抗原活性的重要氨基酸残基.     

金黄色葡萄球菌肠毒素检测的研究进展

金黄色葡萄球菌(Staphylococcus aureus)是一种重要的人畜共患致病菌,广泛存在于自然界中,其产生的肠毒素(staphylococcal enterotoxins,SE)可通过污染食物而导致食物中毒。目前,随着人们对食品安全重视度的加深,国际上已将肠毒素的检测列入食品检验法规,因此建立灵敏、快速的肠毒素检测方法,是食品安全检测的一项重要研究内容。     

Proteomic analysis of exoproteins expressed by enterotoxigenic Staphylococcus aureus strains

Pathogenic bacteria excrete a variety of virulence factors into extracellular medium and to the cell surface which have essential roles in the colonization and insurrection of the host cells, and thus reflect the degree of bacterial pathogenicity. For the exploration of virulence factors expressed in the secreted proteome fraction, different Staphylococcus aureus strains were analyzed using gel-based bottom-up proteomic approach. A total of 119 distinct proteins were identified for the enterotoxin gene cluster (egc) negative and seb gene positive S. aureus American Type Culture Collection (ATCC) 14458 strain by the use of one- and 2-DE based proteomics. Detailed analysis of enterotoxin region of the 2-D map confirmed, beside the highly expressed staphylococcal enterotoxin B (SEB), the presence of enterotoxin-like proteins SElK and SElQ previously predicted by genotyping (Sergeev et al.., J. Clin. Microbiol. 2004, 42, 2134-2143). Exoprotein patterns at the late-exponential (7 h) and stationary (24 h) phases of cellular growth show a high-level similarity in this region. Comparative analysis of enterotoxin region of five S. aureus strains including two clinical isolates (RIMD 31092 and A900322), a food derived strain (AB-8802) with highly prevalent egc positive operon and a nonenterotoxigenic reference strain (ROS) revealed the presence of different known enterotoxins and other virulence factors along with a number of core exoproteins. In addition, production of SElL (RIMD 31092) and SElP (A900322) was demonstrated for the first time at the protein level. Under the experimental conditions applied none of the enterotoxins encoded by the genes of egc operon was identified.     

增强型金黄色葡萄球菌肠毒素C2突变体及其超抗原活性

金黄色葡萄球菌肠毒素C2 (Staphylococcal enterotoxin C2,SEC2)作为一种超级抗原蛋白,极微量即可有效激活机体免疫系统,这一特性可应用于对肿瘤和感染性疾病的辅助治疗.为了增强SEC2的超抗原活性,应用over-lap PCR方法将SEC2中的102～106位GKVTG氨基酸残基分别突变为WWH、WWT和WWP,获得3种突变体ST-1、ST-2和ST-3.三种突变体刺激小鼠淋巴细胞增殖活性和肿瘤细胞生长抑制活性与野生型SEC2相比均有显著提高.ST-1和ST-3的致热活性与野生型SEC2相当,而ST-2的致热活性明显高于野生型SEC2.此外,三种突变体体外刺激淋巴细胞分泌IL-2、IFN-γ和TNF-α的水平也显著提高,这可能是导致突变体具有较高肿瘤细胞生长抑制活性的原因.进一步实验发现,三种突变体刺激下,小鼠脾淋巴细胞mVβ8.2基因的转录水平较野生型SEC2显著增加,暗示突变体对TCR mVβ8.2分子亲和力的提高,可能是其超抗原活性增强的主要原因.     

The effects of subinhibitory concentrations of costus oil on virulence factor production in Staphylococcus aureus

Aim: To determine the antimicrobial activity of costus (Saussurea lappa) oil against Staphylococcus aureus, and to evaluate the influence of subinhibitory concentrations of costus oil on virulence‐related exoprotein production in staph. aureus. Methods and Results: Minimal inhibitory concentrations (MICs) were determined using a broth microdilution method, and the MICs of costus oil against 32 Staph. aureus strains ranged from 0.15 to 0.6 μl ml^?1. The MIC₅₀ and MIC₉₀ were 0.3 and 0.6 μl ml^?1, respectively. Western blot, haemolytic, tumour necrosis factor (TNF) release and real‐time RT‐PCR assays were performed to evaluate the effects of subinhibitory concentrations of costus oil on virulence‐associated exoprotein production in Staph. aureus. The data presented here show that costus oil dose dependently decreased the production of α‐toxin, toxic shock syndrome toxin 1 (TSST‐1) and enterotoxins A and B in both methicillin‐sensitive Staph. aureus (MSSA) and methicillin‐resistant Staph. aureus (MRSA). Conclusion: Costus oil has potent antimicrobial activity against Staph. aureus, and the production of α‐toxin, TSST‐1 and enterotoxins A and B in Staph. aureus was decreased by costus oil. Significance and Impact of the Study: The data suggest that costus oil may deserve further investigation for its potential therapeutic value in treating Staph. aureus infections. Furthermore, costus oil could be rationally applied in food products as a novel food preservative both to inhibit the growth of Staph. aureus and to repress the production of exotoxins, particularly staphylococcal enterotoxins.     

An automated point-of-care system for immunodetection of staphylococcal enterotoxin B

An automated point-of-care (POC) immunodetection system for immunological detection of staphylococcal enterotoxin B (SEB) was designed, fabricated, and tested. The system combines several elements: (i) enzyme-linked immunosorbent assay–lab-on-a-chip (ELISA–LOC) with fluidics, (ii) a charge-coupled device (CCD) camera detector, (iii) pumps and valves for fluid delivery to the ELISA–LOC, (iv) a computer interface board, and (v) a computer for controlling the fluidics, logging, and data analysis of the CCD data. The ELISA–LOC integrates a simple microfluidic system into a miniature 96-well sample plate, allowing the user to carry out immunological assays without a laboratory. The analyte is measured in a sandwich ELISA assay format combined with a sensitive electrochemiluminescence (ECL) detection method. Using the POC system, SEB, a major foodborne toxin, was detected at concentrations as low as 0.1 ng/ml. This is similar to the reported sensitivity of conventional ELISA. The open platform with simple modular fluid delivery automation design described here is interchangeable between detection systems, and because of its versatility it can also be used to automate many other LOC systems, simplifying LOC development. This new POC system is useful for carrying out various immunological and other complex medical assays without a laboratory and can easily be adapted for high-throughput biological screening in remote and resource-poor areas.     

New evidence that the Tyr-157 and Tyr-159 residues of staphylococcal exfoliative toxin B are essential for its toxicity

To determine the active site of exfoliative toxin B (sETB) of Staphylococcus aureus, the etb gene was cloned from an S. aureus SU strain obtained from a patient with impetigo. We prepared a frame shift mutant protein from a recombinant plasmid with a BglII linker inserted into the Tyr-155 codon of the ETB gene (pETB/BglIIL). The recombinant mutant protein (ETB/BglIIL) obtained from Escherichia coli containing pETB/BgIIIL showed no toxicity in neonatal mice and no agglutination activity. The 20-kDa ETB/BglIIL contained 185 amino acid residues. Site-directed mutagenesis was used to introduce mutations at either Tyr-155, Tyr-157, Tyr-159, or Tyr-162. Substitution of any of the Tyr residues decreased exfoliative activity compared with that of native sETB (4,000 EU/ml). Substitution of Tyr-155 with a Phe (ETBYN155) decreased activity 5-fold (800 EU/ml). Substitution of Tyr-157 with Leu (ETB/Y157) decreased activity 80-fold (50 EU/ml) and decreased agglutination titer 5-fold compared with that of native sETB (400,000). Substitution of Tyr-159 with Leu (ETB/Y159)decreased activity 4-fold (1,000 EU/ml). When both Tyr-157 and Tyr-159 were mutated (ETB/Y157-159), both toxicity and antigenicity were completely lost. On an immunodiffusion test, ETBNY157 showed a faint precipitation line, but ETB/BglIIL and ETB/Y157-159 had no activity, showing that the Tyr-157 and Tyr-159 residues are essential for the toxicity and antigenicity of ETB.     

用于检测葡萄球菌肠毒素的免疫芯片技术

免疫芯片是指包被在固相载体上的高密度抗原或抗体微点阵 ,是继基因芯片之后提出的一种新型的生物芯片。在检测大分子物质葡萄球菌肠毒素 (SE)时采用双抗体夹心法。检测时将SEA、SEB、SEC加入反应池中 ,反应后清洗掉未结合的SE ,再加入相应的标记抗体 ,形成固定抗体 待测物 标记抗体的夹心式结构。对影响免疫芯片检测效果的条件进行了优化 ,按优化后的条件进行SEA、SEB、SEC的检测 ,结果表明荧光信号强度随待测物浓度的增加而增加 ,当浓度高于一定值时 ,荧光信号强度趋于一定值 ,本法最低可检测 0.0 1 μg ml的SEA和SEB及 0.1 μg ml的SEC。将此项技术应用于环境和食品中污染物检测领域 ,将会使卫生监督工作水平得到明显的提高。     

Production of cytotoxin VT in enteropathogenic and non-enteropathogenic Eschericha coli strains of porcine origin

Abstract We have investigated the production of verotoxin (VT) in 55 enteropathogenic and 48 non-enteropathogenic Escherichia coli strains of porcine origin, belonging to 48 serotypes. VT cytotoxin was only produced by seven out of the eight enteropathogenic strains with serotypes O138:K81, O139:K82, O141:K85ab and O141:K85ac. Five haemolytic non-enteropathogenic E. coli , four with serotypes O75:K-, O75:K95 and O2:K2, and one not typable, synthesized a new thermolabile product not related with enterotoxin (LT) or VT, and which induced the formation of multinucleate cells in Vero monolayers.